Dr. Reddys Labs (RDY) Tops Q2 EPS by 5c

Dr. Reddys Labs (NYSE: RDY) reported Q2 EPS of $1.00, $0.05 better than the analyst estimate of $0.95. Revenue for the quarter came in at $921 million versus the consensus estimate of $874.08 million.

For earnings history and earnings-related data on Dr. Reddys Labs (RDY) click here.

You May Also Be Interested In

• Trump on Iran: we're trying to work out a deal that's fair
• Coherus and Zumutor to run Phase 1 trial combining ZM008 and Loqtorzi
• Ross Stores (ROST) call put ratio 1 call to 1 put as share price down 3%